Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

N/ACompletedNCT00002064

Palo Alto Medical Foundation

Overview

To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Toxoplasmosis, Cerebral HIV Infections

Interventions

PyrimethamineDRUG

ClindamycinDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Exclusion Criteria Co-existing Condition: Patients with the following conditions are excluded: * Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy. Patients with other opportunistic infections or brain diseases are excluded. Patients with AIDS and cerebral toxoplasmosis.

Locations (1)

Palo Alto Med Foundation

Palo Alto, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.